188 related articles for article (PubMed ID: 38552622)
21. Long-term survival with IDH wildtype glioblastoma: first results from the ETERNITY Brain Tumor Funders' Collaborative Consortium (EORTC 1419).
Hertler C; Felsberg J; Gramatzki D; Le Rhun E; Clarke J; Soffietti R; Wick W; Chinot O; Ducray F; Roth P; McDonald K; Hau P; Hottinger AF; Reijneveld J; Schnell O; Marosi C; Glantz M; Darlix A; Lombardi G; Krex D; Glas M; Reardon DA; van den Bent M; Lefranc F; Herrlinger U; Razis E; Carpentier AF; Phillips S; Rudà R; Wick A; Tabouret E; Meyronet D; Maurage CA; Rushing E; Rapkins R; Bumes E; Hegi M; Weyerbrock A; Aregawi D; Gonzalez-Gomez C; Pellerino A; Klein M; Preusser M; Bendszus M; Golfinopoulos V; von Deimling A; Gorlia T; Wen PY; Reifenberger G; Weller M
Eur J Cancer; 2023 Aug; 189():112913. PubMed ID: 37277265
[TBL] [Abstract][Full Text] [Related]
22. Prognostic relevance of programmed cell death ligand 1 expression in glioblastoma.
Lee KS; Lee K; Yun S; Moon S; Park Y; Han JH; Kim CY; Lee HS; Choe G
J Neurooncol; 2018 Feb; 136(3):453-461. PubMed ID: 29147863
[TBL] [Abstract][Full Text] [Related]
23. Generative adversarial network for glioblastoma ensures morphologic variations and improves diagnostic model for isocitrate dehydrogenase mutant type.
Park JE; Eun D; Kim HS; Lee DH; Jang RW; Kim N
Sci Rep; 2021 May; 11(1):9912. PubMed ID: 33972663
[TBL] [Abstract][Full Text] [Related]
24. Updates in IDH-Wildtype Glioblastoma.
Melhem JM; Detsky J; Lim-Fat MJ; Perry JR
Neurotherapeutics; 2022 Oct; 19(6):1705-1723. PubMed ID: 35641844
[TBL] [Abstract][Full Text] [Related]
25. Congress of neurological surgeons systematic review and evidence-based guidelines update on the role of neuropathology in the management of progressive glioblastoma in adults.
Goodman AL; Velázquez Vega JE; Glenn C; Olson JJ
J Neurooncol; 2022 Jun; 158(2):179-224. PubMed ID: 35648306
[TBL] [Abstract][Full Text] [Related]
26. Partial resection offers an overall survival benefit over biopsy in MGMT-unmethylated IDH-wildtype glioblastoma patients.
Hallaert G; Pinson H; Vanhauwaert D; Van den Broecke C; Van Roost D; Boterberg T; Kalala JP
Surg Oncol; 2020 Dec; 35():515-519. PubMed ID: 33152608
[TBL] [Abstract][Full Text] [Related]
27. Machine Learning and Artificial Intelligence-driven Spatial Analysis of the Tumor Immune Microenvironment in Pathology Slides.
Xu H; Cong F; Hwang TH
Eur Urol Focus; 2021 Jul; 7(4):706-709. PubMed ID: 34353733
[TBL] [Abstract][Full Text] [Related]
28. Extent of resection of peritumoral diffusion tensor imaging-detected abnormality as a predictor of survival in adult glioblastoma patients.
Yan JL; van der Hoorn A; Larkin TJ; Boonzaier NR; Matys T; Price SJ
J Neurosurg; 2017 Jan; 126(1):234-241. PubMed ID: 27058207
[TBL] [Abstract][Full Text] [Related]
29. A fully automated artificial intelligence method for non-invasive, imaging-based identification of genetic alterations in glioblastomas.
Calabrese E; Villanueva-Meyer JE; Cha S
Sci Rep; 2020 Jul; 10(1):11852. PubMed ID: 32678261
[TBL] [Abstract][Full Text] [Related]
30. Higher cytolytic score correlates with an immunosuppressive tumor microenvironment and reduced survival in glioblastoma.
Haddad AF; Chen JS; Oh T; Pereira MP; Joshi RS; Aghi MK
Sci Rep; 2020 Oct; 10(1):17580. PubMed ID: 33067480
[TBL] [Abstract][Full Text] [Related]
31. Targeting copper death genotyping associated gene RARRES2 suppresses glioblastoma progression and macrophages infiltration.
Yan T; Yang H; Meng Y; Li H; Jiang Q; Liu J; Xu C; Xue Y; Xu J; Song Y; Chu X; Wang L; Chen X; Che F
Cancer Cell Int; 2023 May; 23(1):105. PubMed ID: 37246211
[TBL] [Abstract][Full Text] [Related]
32. Quantitative Analysis of the Cellular Microenvironment of Glioblastoma to Develop Predictive Statistical Models of Overall Survival.
Yuan JX; Bafakih FF; Mandell JW; Horton BJ; Munson JM
J Neuropathol Exp Neurol; 2016 Dec; 75(12):1110-1123. PubMed ID: 27815396
[TBL] [Abstract][Full Text] [Related]
33. Classification of IDH wild-type glioblastoma tumorspheres into low- and high-invasion groups based on their transcriptional program.
Park J; Shim JK; Lee M; Kim D; Yoon SJ; Moon JH; Kim EH; Park JY; Chang JH; Kang SG
Br J Cancer; 2023 Oct; 129(7):1061-1070. PubMed ID: 37558923
[TBL] [Abstract][Full Text] [Related]
34. H3-/IDH-wild type pediatric glioblastoma is comprised of molecularly and prognostically distinct subtypes with associated oncogenic drivers.
Korshunov A; Schrimpf D; Ryzhova M; Sturm D; Chavez L; Hovestadt V; Sharma T; Habel A; Burford A; Jones C; Zheludkova O; Kumirova E; Kramm CM; Golanov A; Capper D; von Deimling A; Pfister SM; Jones DTW
Acta Neuropathol; 2017 Sep; 134(3):507-516. PubMed ID: 28401334
[TBL] [Abstract][Full Text] [Related]
35. Concordance analysis and diagnostic test accuracy review of IDH1 immunohistochemistry in glioblastoma.
Pyo JS; Kim NY; Kim RH; Kang G
Brain Tumor Pathol; 2016 Oct; 33(4):248-254. PubMed ID: 27638721
[TBL] [Abstract][Full Text] [Related]
36. Predictive value of MGMT promoter methylation on the survival of TMZ treated
Chai R; Li G; Liu Y; Zhang K; Zhao Z; Wu F; Chang Y; Pang B; Li J; Li Y; Jiang T; Wang Y
Cancer Biol Med; 2021 Feb; 18(1):272-282. PubMed ID: 33628600
[TBL] [Abstract][Full Text] [Related]
37. Characteristics and Prognosis of Tumor-Related Epilepsy During Tumor Evolution in Patients With
Pallud J; Roux A; Moiraghi A; Aboubakr O; Elia A; Guinard E; Oppenheim C; Tauziede-Espariat A; Parraga E; Gavaret M; Chrètien F; Huberfeld G; Zanello M
Neurology; 2024 Jan; 102(1):e207902. PubMed ID: 38165369
[TBL] [Abstract][Full Text] [Related]
38. Current perspectives on diffuse midline glioma and a different role for the immune microenvironment compared to glioblastoma.
Pachocki CJ; Hol EM
J Neuroinflammation; 2022 Nov; 19(1):276. PubMed ID: 36403059
[TBL] [Abstract][Full Text] [Related]
39. The PTEN-associated immune prognostic signature reveals the landscape of the tumor microenvironment in glioblastoma.
Yu J; Lai M; Zhou Z; Zhou J; Hu Q; Li J; Li H; Chen L; Wen L; Zhou M; Cai L
J Neuroimmunol; 2023 Mar; 376():578034. PubMed ID: 36791582
[TBL] [Abstract][Full Text] [Related]
40. Glioblastoma multiforme: Metabolic differences to peritumoral tissue and IDH-mutated gliomas revealed by mass spectrometry imaging.
Kampa JM; Kellner U; Marsching C; Ramallo Guevara C; Knappe UJ; Sahin M; Giampà M; Niehaus K; Bednarz H
Neuropathology; 2020 Dec; 40(6):546-558. PubMed ID: 32662157
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
